Skip Navigation
Skip to contents
Results by Year

View Wide

Filter

ARTICLE TYPE

PUBLICATION DATE

5 results
Display

A case of allopurinol-induced granulomatous hepatitis with ductopenia and cholestasis

Yoon JY, Min SY, Park JY, Hong SG, Park SJ, Paik SY, Park YM

Allopurinol-induced hypersensitivity syndrome is characterized by an idiosyncratic reaction involving multiple-organs, which usually begins 2 to 6 weeks after starting allopurinol. In rare cases, the adverse reactions to allopurinol are...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A case of amoxicillin-induced hepatocellular liver injury with bile-duct damage

Kim JS, Jang YR, Lee JW, Kim JY, Jung YK, Chung DH, Kwon OS, Kim YS, Choi DJ, Kim JH

Amoxicillin, an antibiotic that is widely prescribed for various infections, is associated with a very low rate of drug-induced liver injury; hepatitis and cholestasis are rare complications. Here we present...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A case of flutamide-induced acute cholestatic hepatitis: a case report

Lee HW, Chung JP, Lee KS, Kim KC, Lee KS, Chon CY, Park IS, Kim HG

Flutamide, an oral nonsteroidal, antiandrogenic, anilid compound which inhibits the uptake and binding of androgens to nuclear receptors in the prostate, is used with or without LH-RH analogues for treatment...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A case of ticlopidine induced acute cholestatic hepatitis and pure red cell aplasia

Lee JY, Park EB, Ahn JH, Suh SJ, Jung YK, Kim JH, Shin BK, Yang JH, Yeon JE, Byun KS

Ticlopidine inhibits platelet aggregation and provides beneficial secondary prevention of cerebrovascular and coronary artery disease. Frequently reported adverse effects of ticlopidine include diarrhea, nausea, and rash. However, to our knowledge,...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A Case of Acute Cholestatic Hepatitis Associated with Orlistat

Kim DH, Lee EH, Hwang JC, Jeung JH, Kim DH, Cheong JY, Cho SW, Kim YB

  • KMID: 863103
  • Korean J Hepatol.
  • 2002 Sep;8(3):317-320.
Orlistat(Xenical(R), Roche) is considered a safe and effective drug to treat obesity by reduced absorption of 30% digested fat. To date, no serious adverse effects affecting the liver have...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr